Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary Amended on May 16, 2022 – the version known today is shown.
You are looking at Q4 2021. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 34.5B USD
- Positions
- 105
- Share of the ten largest
- 37.6%
The ten largest positions Q4 2021
- Ginkgo Bioworks Holdings Inc 8.2%unchanged
- GE Aerospace 4.9%▲ +6.6%
- T-Mobile US 4.4%▲ +28.6%
- Humana 3.6%▼ −11.4%
- Brookfield Asset Mgmt Inc 3.1%▲ +3.6%
- Microsoft 2.9%▼ −19.5%
- Parker Hannifin 2.8%▼ −1.4%
- Amazon 2.7%▲ +37.1%
- Roivant Sciences Ltd 2.6%new
- Visa Inc. 2.5%▲ +50.6%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q4 2021
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| AMZN Amazon | 2.7% | 278,199 | 927.6M USD | +37.1% increased | Q2 2015 27 quarters |
| MSFT Microsoft | 2.9% | 2,932,762 | 986.3M USD | −19.5% reduced | Q2 2016 23 quarters |
| V Visa Inc. | 2.5% | 3,971,579 | 860.7M USD | +50.6% increased | Q3 2016 22 quarters |
| Catalent Inc | 0.4% | 1,139,354 | 145.9M USD | −2.0% reduced | Q1 2018 16 quarters |
| CNC Centene Corporation | 2.1% | 8,618,638 | 710.2M USD | −12.8% reduced | Q2 2018 15 quarters |
| BSX Boston Scientific | 2.3% | 18,961,501 | 805.5M USD | +176.1% increased | Q3 2018 14 quarters |
| Adaptive Biotechnologies Cor | 2.4% | 29,993,708 | 841.6M USD | unchanged | Q2 2019 11 quarters |
| Bridgebio Pharma Inc | 1.3% | 26,620,991 | 444.0M USD | unchanged | Q2 2019 11 quarters |
| Avantor Inc | 1.1% | 8,787,342 | 370.3M USD | +23.4% increased | Q2 2019 11 quarters |
| AIZ Assurant | 0.8% | 1,723,771 | 268.7M USD | −5.2% reduced | Q2 2019 11 quarters |
| FTV Fortive | 1.9% | 8,484,942 | 647.3M USD | −21.5% reduced | Q3 2019 10 quarters |
| Guardant Health Inc | 1.5% | 5,074,389 | 507.5M USD | +3.7% increased | Q3 2019 10 quarters |
| Molina Healthcare Inc | 0.4% | 447,686 | 142.4M USD | −52.1% reduced | Q3 2019 10 quarters |
| TMUS T-Mobile US | 4.4% | 13,148,287 | 1.5B USD | +28.6% increased | Q1 2020 8 quarters |
| CB Chubb Limited | 2.1% | 3,691,765 | 713.7M USD | +21.4% increased | Q1 2020 8 quarters |
| PH Parker Hannifin | 2.8% | 3,056,921 | 972.5M USD | −1.4% reduced | Q2 2020 7 quarters |
| Api Group Corp | 2.5% | 33,333,333 | 859.0M USD | unchanged | Q2 2020 7 quarters |
| Royalty Pharma PLC | 1.2% | 10,315,378 | 411.1M USD | +149.1% increased | Q2 2020 7 quarters |
| Zentalis Pharmaceuticals Inc | 0.5% | 2,118,284 | 178.1M USD | unchanged | Q2 2020 7 quarters |
| TMO Thermo Fisher Scientific | 0.4% | 211,058 | 140.8M USD | +15.8% increased | Q2 2020 7 quarters |
| Pvh Corporation | 0.2% | 768,809 | 82.0M USD | −33.8% reduced | Q2 2020 7 quarters |
| ZBH Zimmer Biomet | 0.9% | 2,496,245 | 317.1M USD | −26.8% reduced | Q3 2020 6 quarters |
| Laboratory Corp Amer HLDGS | 0.8% | 850,147 | 267.1M USD | +7.4% increased | Q3 2020 6 quarters |
| Inhibrx Inc | 0.7% | 5,305,866 | 231.7M USD | unchanged | Q3 2020 6 quarters |
| Fleetcor Technologies Inc | 0.6% | 983,391 | 220.1M USD | −60.2% reduced | Q3 2020 6 quarters |
| PODD Insulet Corporation | 0.5% | 678,194 | 180.4M USD | −33.1% reduced | Q3 2020 6 quarters |
| BMY Bristol Myers Squibb | 0.3% | 1,815,619 | 113.2M USD | −74.1% reduced | Q3 2020 6 quarters |
| Karuna Therapeutics Inc | 0.3% | 863,664 | 113.1M USD | −0.6% reduced | Q3 2020 6 quarters |
| Pmv Pharmaceuticals Inc | 0.1% | 1,790,284 | 41.4M USD | unchanged | Q3 2020 6 quarters |
| GE GE Aerospace | 4.9% | 18,041,156 | 1.7B USD | +6.6% increased | Q4 2020 5 quarters |
| META Meta Platforms | 1.8% | 1,886,516 | 634.5M USD | +10.6% increased | Q4 2020 5 quarters |
| Match Group Inc New | 0.7% | 1,899,574 | 251.2M USD | +39.2% increased | Q4 2020 5 quarters |
| PANW Palo Alto Networks | 0.6% | 395,157 | 220.0M USD | −69.0% reduced | Q4 2020 5 quarters |
| MRSH Marsh McLennan | 0.6% | 1,261,570 | 219.3M USD | +9.1% increased | Q4 2020 5 quarters |
| NOW ServiceNow | 0.4% | 224,261 | 145.6M USD | −59.9% reduced | Q4 2020 5 quarters |
| Acadia Healthcare Company In | 0.4% | 2,090,576 | 126.9M USD | −0.6% reduced | Q4 2020 5 quarters |
| 4D Molecular Therapeutics In | 0.3% | 3,937,914 | 86.4M USD | unchanged | Q4 2020 5 quarters |
| Kinnate Biopharma Inc | < 0.1% | 1,820,462 | 32.3M USD | unchanged | Q4 2020 5 quarters |
| Coupa Software Inc | 1.9% | 4,168,030 | 658.8M USD | +6.4% increased | Q1 2021 4 quarters |
| AMP Ameriprise Financial | 1.3% | 1,453,796 | 438.6M USD | +3.8% increased | Q1 2021 4 quarters |
| DE Deere & Company | 0.9% | 933,418 | 320.1M USD | +29.9% increased | Q1 2021 4 quarters |
| Tenet Healthcare Corp | 0.8% | 3,211,241 | 262.3M USD | −4.3% reduced | Q1 2021 4 quarters |
| Lithia Mtrs Inc | 0.7% | 791,084 | 234.9M USD | −1.5% reduced | Q1 2021 4 quarters |
| Zai Lab Ltd | 0.6% | 3,018,958 | 189.7M USD | +2.9% increased | Q1 2021 4 quarters |
| CRL Charles River Laboratories | 0.4% | 390,129 | 147.0M USD | +119.9% increased | Q1 2021 4 quarters |
| RUN Sunrun | 0.4% | 3,823,259 | 131.1M USD | −56.6% reduced | Q1 2021 4 quarters |
| Edgewise Therapeutics Inc | 0.1% | 2,727,249 | 41.7M USD | unchanged | Q1 2021 4 quarters |
| Pharvaris N V | 0.1% | 2,455,536 | 38.8M USD | +2.7% increased | Q1 2021 4 quarters |
| Orion Acquisition Corp | 0.1% | 3,669,272 | 36.1M USD | −0.1% reduced | Q1 2021 4 quarters |
| Gracell Biotechnologies Inc | < 0.1% | 491,647 | 3.0M USD | −63.8% reduced | Q1 2021 4 quarters |
| HUM Humana | 3.6% | 2,663,368 | 1.2B USD | −11.4% reduced | Q2 2021 3 quarters |
| Brookfield Asset Mgmt Inc | 3.1% | 17,603,102 | 1.1B USD | +3.6% increased | Q2 2021 3 quarters |
| Figs Inc | 1.2% | 14,742,689 | 406.3M USD | unchanged | Q2 2021 3 quarters |
| BKNG Booking Holdings | 0.9% | 128,278 | 307.8M USD | −4.6% reduced | Q2 2021 3 quarters |
| JD JD.com (ADR) | 0.8% | 3,765,921 | 263.9M USD | −48.4% reduced | Q2 2021 3 quarters |
| Intellia Therapeutics Inc | 0.5% | 1,579,536 | 186.8M USD | +23.4% increased | Q2 2021 3 quarters |
| Zoominfo Technologies Inc | 0.5% | 2,706,305 | 173.7M USD | −29.9% reduced | Q2 2021 3 quarters |
| Peloton Interactive Inc | 0.4% | 3,951,576 | 141.3M USD | −39.1% reduced | Q2 2021 3 quarters |
| Adapthealth Corp | 0.3% | 3,949,783 | 96.6M USD | −3.0% reduced | Q2 2021 3 quarters |
| Talaris Therapeutics Inc | 0.1% | 3,289,617 | 50.3M USD | unchanged | Q2 2021 3 quarters |
| Day One Biopharmaceuticals I | < 0.1% | 1,157,424 | 19.5M USD | −4.5% reduced | Q2 2021 3 quarters |
| Ginkgo Bioworks Holdings Inc | 8.2% | 339,055,144 | 2.8B USD | unchanged | Q3 2021 2 quarters |
| CMCSA Comcast | 2.1% | 14,213,091 | 715.3M USD | +39.7% increased | Q3 2021 2 quarters |
| UBER Uber | 1.3% | 10,584,794 | 443.8M USD | +65.6% increased | Q3 2021 2 quarters |
| Hdfc Bank Ltd | 0.9% | 4,852,938 | 315.8M USD | +189.0% increased | Q3 2021 2 quarters |
| Mcdonalds Corp | 0.7% | 958,248 | 256.9M USD | −68.0% reduced | Q3 2021 2 quarters |
| WTW Willis Towers Watson | 0.7% | 962,328 | 228.5M USD | −17.0% reduced | Q3 2021 2 quarters |
| Farfetch Ltd | 0.6% | 5,946,096 | 198.8M USD | −48.5% reduced | Q3 2021 2 quarters |
| TSLA Tesla, Inc. | 0.5% | 173,672 | 183.5M USD | −54.8% reduced | Q3 2021 2 quarters |
| Procept Biorobotics Corp | 0.4% | 4,907,892 | 122.7M USD | unchanged | Q3 2021 2 quarters |
| Olaplex HLDGS Inc | 0.1% | 1,613,189 | 47.0M USD | −46.6% reduced | Q3 2021 2 quarters |
| Icosavax Inc | 0.1% | 1,796,800 | 41.1M USD | −3.0% reduced | Q3 2021 2 quarters |
| Rallybio Corp | 0.1% | 4,194,777 | 40.0M USD | unchanged | Q3 2021 2 quarters |
| Vtex | < 0.1% | 3,023,280 | 32.4M USD | −0.6% reduced | Q3 2021 2 quarters |
| Nuvalent Inc | < 0.1% | 1,647,671 | 31.4M USD | unchanged | Q3 2021 2 quarters |
| Celldex Therapeutics Inc New | < 0.1% | 757,881 | 29.3M USD | −0.6% reduced | Q3 2021 2 quarters |
| On Hldg AG | < 0.1% | 300,000 | 11.3M USD | unchanged | Q3 2021 2 quarters |
| Meli Kaszek Pioneer Corp | < 0.1% | 880,185 | 10.2M USD | −12.0% reduced | Q3 2021 2 quarters |
| SEMA4 Holdings Corp | < 0.1% | 1,226,307 | 5.5M USD | −59.1% reduced | Q3 2021 2 quarters |
| Roivant Sciences Ltd | 2.6% | 88,238,700 | 889.4M USD | new | Q4 2021 1 quarter |
| TWLO Twilio | 2.3% | 2,980,398 | 784.9M USD | new | Q4 2021 1 quarter |
| WDAY Workday, Inc. | 1.4% | 1,751,589 | 478.5M USD | new | Q4 2021 1 quarter |
| AON Aon plc | 1.3% | 1,510,517 | 454.0M USD | new | Q4 2021 1 quarter |
| RIVN Rivian Automotive | 1.0% | 3,204,389 | 332.3M USD | new | Q4 2021 1 quarter |
| Global E Online Ltd | 0.9% | 5,038,891 | 319.4M USD | new | Q4 2021 1 quarter |
| Biomarin Pharmaceutical Inc | 0.7% | 2,869,947 | 253.6M USD | new | Q4 2021 1 quarter |
| TTWO Take-Two Interactive | 0.6% | 1,203,961 | 214.0M USD | new | Q4 2021 1 quarter |
| FDX FedEx | 0.5% | 655,242 | 169.5M USD | new | Q4 2021 1 quarter |
| AIG American International Group | 0.5% | 2,903,295 | 165.1M USD | new | Q4 2021 1 quarter |
| LI Li Auto | 0.4% | 4,485,985 | 144.0M USD | new | Q4 2021 1 quarter |
| SE Sea Limited (ADR) | 0.3% | 440,129 | 98.5M USD | new | Q4 2021 1 quarter |
| WDC Western Digital | 0.2% | 1,311,029 | 85.5M USD | new | Q4 2021 1 quarter |
| Zillow Group Inc | 0.2% | 1,258,215 | 80.3M USD | new | Q4 2021 1 quarter |
| IFF International Flavors & Fragrances | 0.2% | 510,985 | 77.0M USD | new | Q4 2021 1 quarter |
| XYZ Block, Inc. | 0.2% | 454,947 | 73.5M USD | new | Q4 2021 1 quarter |
| XPEV XPeng | 0.2% | 1,456,496 | 73.3M USD | new | Q4 2021 1 quarter |
| Amedisys Inc | 0.2% | 391,131 | 63.3M USD | new | Q4 2021 1 quarter |
| KKR KKR & Co. | 0.2% | 806,081 | 60.1M USD | new | Q4 2021 1 quarter |
| BEKE KE Holdings | 0.2% | 2,920,256 | 58.8M USD | new | Q4 2021 1 quarter |
| PHM PulteGroup | 0.2% | 913,668 | 52.2M USD | new | Q4 2021 1 quarter |
| Biohaven Pharmactl Hldg Co L | 0.1% | 348,783 | 48.1M USD | new | Q4 2021 1 quarter |
| APO Apollo Global Management | 0.1% | 538,212 | 39.0M USD | new | Q4 2021 1 quarter |
| Abiomed Inc | < 0.1% | 82,572 | 29.7M USD | new | Q4 2021 1 quarter |
| Tdcx Inc | < 0.1% | 1,014,497 | 19.4M USD | new | Q4 2021 1 quarter |
| Lianbio | < 0.1% | 1,500,000 | 9.2M USD | new | Q4 2021 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 2 positions in convertible bonds and bonds worth 217.0M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Guardant Health Inc principal 120.0M USD 122.0M USD
- Coupa Software Inc principal 100.0M USD 95.0M USD
Breakdown by sector
- Industrials 12.7%
- Health Care 10.6%
- Financials 10.2%
- Communication Services 9.0%
- Technology 7.8%
- Consumer Discretionary 5.2%
- Materials 0.2%
- not in our coverage 44.3%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors